Combination phase I/II study with EN 3356 in patients with metastatic castration-resistant prostate cancer
Latest Information Update: 05 Feb 2014
At a glance
- Drugs EN 3356 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Feb 2014 New trial record